Conmed
(NYSE:CNMD)
$80.14
0[0.00%]
Last update: 4:00PM Get Real Time Here
Consensus Rating1
Buy
Highest Price Target1
$175.00
Lowest Price Target1
$85.00
Consensus Price Target1
$126.30

Conmed Stock (NYSE:CNMD), Analyst Ratings, Price Targets, Predictions

Conmed Corp has a consensus price target of $126.3, established from looking at the 36 latest analyst ratings. The last 3 analyst ratings were released from Piper Sandler, JP Morgan, and Wells Fargo on February 1, 2024. With an average price target of $104.33 between Piper Sandler, JP Morgan, and Wells Fargo, there's an implied 30.19% upside for Conmed Corp from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Oct 23
3
1
Feb
3
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Piper Sandler
JP Morgan
Wells Fargo
Needham
Stifel

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Conmed

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/01/2024CNMDBuy Now
Conmed
$80.1424.78%Piper Sandler
Matt O'Brien
$130 → $100MaintainsOverweightGet Alert
02/01/2024CNMDBuy Now
Conmed
$80.1443.5%JP Morgan
Robbie Marcus
$135 → $115MaintainsOverweightGet Alert
02/01/2024CNMDBuy Now
Conmed
$80.1422.29%Wells Fargo
Durgesh Chopra
$107 → $98MaintainsEqual-WeightGet Alert
02/01/2024CNMDBuy Now
Conmed
$80.1460.97%Needham
Mike Matson
$119 → $129MaintainsBuyGet Alert
10/27/2023CNMDBuy Now
Conmed
$80.1462.22%Piper Sandler
Matt O'Brien
$145 → $130MaintainsOverweightGet Alert
10/26/2023CNMDBuy Now
Conmed
$80.1449.74%Stifel
Rick Wise
$136 → $120MaintainsBuyGet Alert
10/26/2023CNMDBuy Now
Conmed
$80.1433.52%Wells Fargo
Durgesh Chopra
$123 → $107MaintainsEqual-WeightGet Alert
10/26/2023CNMDBuy Now
Conmed
$80.1448.49%Needham
Mike Matson
$140 → $119MaintainsBuyGet Alert
07/27/2023CNMDBuy Now
Conmed
$80.1480.93%JP Morgan
Robbie Marcus
$125 → $145MaintainsOverweightGet Alert
07/27/2023CNMDBuy Now
Conmed
$80.1474.69%Needham
Mike Matson
$139 → $140MaintainsBuyGet Alert
07/27/2023CNMDBuy Now
Conmed
$80.1475.94%Keybanc
Matthew Mishan
$131 → $141MaintainsOverweightGet Alert
07/24/2023CNMDBuy Now
Conmed
$80.1473.45%Needham
Mike Matson
→ $139ReiteratesBuy → BuyGet Alert
06/05/2023CNMDBuy Now
Conmed
$80.1473.45%Needham
Mike Matson
$135 → $139MaintainsBuyGet Alert
05/22/2023CNMDBuy Now
Conmed
$80.1474.69%CL King
Kristen Stewart
→ $140Initiates → BuyGet Alert
04/27/2023CNMDBuy Now
Conmed
$80.1462.22%Stifel
Rick Wise
$118 → $130MaintainsBuyGet Alert
04/27/2023CNMDBuy Now
Conmed
$80.1459.72%Piper Sandler
Matt O'Brien
$118 → $128MaintainsOverweightGet Alert
04/27/2023CNMDBuy Now
Conmed
$80.1448.49%Wells Fargo
Durgesh Chopra
$96 → $119MaintainsEqual-WeightGet Alert
04/27/2023CNMDBuy Now
Conmed
$80.1468.46%Needham
Mike Matson
$122 → $135MaintainsBuyGet Alert
04/27/2023CNMDBuy Now
Conmed
$80.1463.46%Keybanc
Matthew Mishan
$124 → $131MaintainsOverweightGet Alert

FAQ

Q

What is the target price for Conmed (CNMD)?

A

The latest price target for Conmed (NYSE: CNMD) was reported by Piper Sandler on February 1, 2024. The analyst firm set a price target for $100.00 expecting CNMD to rise to within 12 months (a possible 24.78% upside). 19 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Conmed (CNMD)?

A

The latest analyst rating for Conmed (NYSE: CNMD) was provided by Piper Sandler, and Conmed maintained their overweight rating.

Q

When was the last upgrade for Conmed (CNMD)?

A

The last upgrade for Conmed Corp happened on March 27, 2023 when Keybanc raised their price target to $124. Keybanc previously had a sector weight for Conmed Corp.

Q

When was the last downgrade for Conmed (CNMD)?

A

There is no last downgrade for Conmed.

Q

When is the next analyst rating going to be posted or updated for Conmed (CNMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Conmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Conmed was filed on February 1, 2024 so you should expect the next rating to be made available sometime around February 1, 2025.

Q

Is the Analyst Rating Conmed (CNMD) correct?

A

While ratings are subjective and will change, the latest Conmed (CNMD) rating was a maintained with a price target of $130.00 to $100.00. The current price Conmed (CNMD) is trading at is $80.14, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch